Sugammadex Anaphylaxis: Mechanisms, Diagnosis, and Incidence

Affiliations

¹ Department of Anaesthesia, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
² Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom; Department of Anaesthesia and Critical Care, Belfast Health and Social Care Trust, Belfast, United Kingdom.
³ Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Louise Savic et al. Anesthesiology. 2025.

. 2025 Jul 1;143(1):199-204.

doi: 10.1097/ALN.0000000000005431. Epub 2025 May 20.

¹ Department of Anaesthesia, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
² Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom; Department of Anaesthesia and Critical Care, Belfast Health and Social Care Trust, Belfast, United Kingdom.
³ Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

No abstract available

References

1. O’Reilly-Shah VN, Wolf FA, Jabaley CS, Lynde GC: Using a worldwide in-app survey to explore sugammadex usage patterns: A prospective observational study. Br J Anaesth 2017; 119:333–5
1. Merck & Co, Inc.: Merck announces fourth-quarter and full-year 2023 financial results. Available at: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-... . Accessed October 30, 2024.
1. Mertes PM, Ebo DG, Garcez T, et al.: Comparative epidemiology of suspected perioperative hypersensitivity reactions. Br J Anaesth 2019; 123:e16–28
1. Brull SJ, Meistelman C, Nemes R, de Boer HD, Thilen S, Eriksson LI: Pharmacolocy of neuromuscular blocking drugs and antagonists (reversal agents), Miller’s Anesthesia. Edited by M Gropper, Philadelphia, Elsevier, 2024, pp. 674–741
1. Johnson KB, Chacin R: Clarifying the grey space of sugammadex induced bradycardia. Curr Opin Anaesthesiol 2023; 36:422–7